Clinical Trial Update: Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pathophysiology of neurodegeneration in late-life depression using AV45+THK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-life Depression
• Major Depressive Disorder

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED